Results 51 to 60 of about 4,427,643 (140)

Capillary Dropout: A Novel Fluorescein Angiography Finding in Primary Vitreoretinal Lymphoma

, 2017
Tissue diagnosis with vitreous and/or retinal biopsy usually confirms the diagnosis of primary vitreoretinal lymphoma. Multiple imaging modalities like fundus fluorescein angiography, fundus autofluorescence, and optical coherence tomography have been ...
Ramesh Venkatesh, Prachi Gurav, Arpan Gandhi, Prachi Abhishek Dave   +3 more
core   +1 more source

Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse

, 2018
BackgroundVitreoretinal lymphomas belong to the family of central nervous system (CNS) lymphomas. The optimal approach for the treatment of isolated primary vitreoretinal lymphoma is unclear because of the lack of large comparative clinical series ...
Robert Pytlik, Aneta Klimova, Jana Karolova, Ivan Spicka, Petra Svozilkova, Jarmila Heissigerova, Katerina Mrazova, Eva Rihova, Michaela Brichova   +8 more
core   +1 more source

A pilot study of the use of dynamic analysis of cell-free DNA from aqueous humor and vitreous fluid for the diagnosis and treatment monitoring of vitreoretinal lymphomas

Haematologica, 2022
The diagnosis of vitreoretinal lymphoma (VRL), a rare subtype of primary central nervous system lymphoma, is challenging. We aimed to investigate the mutational landscape of VRL by sequencing circulating tumor DNA (ctDNA) from aqueous humor (AH) and/or ...
Xiaoxiao Wang, Wenru Su, Yan Gao, Yanfen Feng, Xiaoxia Wang, Xiaoqing Chen, Yunwei Hu, Yutong Ma, Qiuxiang Ou, Dan Liang, Huiqiang Huang   +10 more
doaj   +1 more source

Primary Vitreoretinal Lymphoma Presenting as a Posterior Capsule Plaque

, 2018
Primary vitreoretinal lymphoma (PVRL) can be a diagnostic challenge and commonly presents as a partially steroid-responsive vitritis or as subretinal cream-colored infiltrates.
Sander R. Dubovy, Garoon, Robert B, Thomas A. Albini, Jay S. Duker, Rehan M. Hussain, Hussain, Rehan M, Dubovy, Sander R, Robert B. Garoon, Duker, Jay S, Albini, Thomas A   +9 more
core   +1 more source

Presenting Clinical Features of Vitreoretinal Lymphoma

Clinical &Experimental Ophthalmology, Volume 54, Issue 4, Page 522-536, May/June 2026.
ABSTRACT Background Vitreoretinal lymphoma is a rare cancer, widely recognised to present diagnostic challenges. We aimed to report information that would support the clinician in considering this diagnosis. Methods We interrogated the International Vitreoretinal B‐Cell Lymphoma Registry for clinical data from patients newly diagnosed with ...
The International Vitreoretinal B‐Cell Lymphoma Registry Investigator Group, Mara Albert‐Fort, Sofia Androudi, Neni Anggraini, Atitaya Apivatthakakul, J. Fernando Arevalo, Meghan K. Berkenstock, Ester Carreño, Anita S.Y. Chan, Soon‐Phaik Chee, Fred K. Chen, Janejit Choovuthayakorn, Luca Cimino, Elisa E. Cornish, Gábor G. Deák, Alexandra L. Farrall, Christina J. Flaxel, Marion Funk, Zsuzsanna Gehl, Pietro Gentile, Debra A. Goldstein, John A. Gonzales, Fabrizio Gozzi, Antonio Hernández‐Pons, Samar Issa, Timothy M. Janetos, Hyeong Min Kim, Min Kim, Jared E. Knickelbein, Zachary A. Kroeger, Paradee Kunavisarut, Rina La Distia Nora, Seung Min Lee, Lyndell L. Lim, Ming Lee Lin, Victor Llorenç, Yunhua Loo, Lucía Martínez‐Costa, Janet M. Matthews, Peter J. McCluskey, David L. McKay, Matteo Menean, Elisabetta Miserocchi, Manabu Mochizuki, Rachael L. Niederer, Roderick F. O’day, Amy S. Pai, Alan G. Palestine, Kessara Pathanapitoon, Mark H.B. Radford, Josephine Richards, Sukhum Silpa‐archa, Joanne L. Sims, Justine R. Smith, Robert T. Swan, Yukiko Terada, Daniel V. Vasconcelos‐Santos, Anagha Vaze, Samanthila Waduthantri, Travers R.E. Weaver, Keryn L. Williams, Se Joon Woo, Richard J. Woodman, Frances Wu, Christine Younan   +64 more
wiley   +1 more source

The molecular hallmarks of primary and secondary vitreoretinal lymphoma [PDF]

, 2022
Vitreoretinal lymphoma (VRL) is a rare subtype of diffuse large B-cell lymphoma (DLBCL) considered a variant of primary central nervous system lymphoma (PCNSL).
Szurman, P, Quintanilla-Martinez, L, Quintanilla Martinez, Leticia, Bonzheim, Irina, Salaverria Frigola, Itziar, Schittenhelm, J, Gekeler, F, Steinhilber, Julia, Salmeron-Villalobos, J, Bussgen, M, Spitzer, MS, Salaverria, I, Fend, F, Szurman, Peter, Bonzheim, I, Gekeler, Florian, Schittenhelm, Jens, Susskind, D, Steinhilber, J, Büssgen, Melanie, Campo, E, Salmerón Villalobos, Julia, Campo Güerri, Elias, Sander, Philip, Süsskind, Daniela, Coupland, SE, Fend, Falko, Kohler, E, Sander, P, Spitzer, Martin S., Coupland, Sarah E., Kohler, Esther   +31 more
core   +1 more source

2026 Update on the Management of Diffuse Large B‐Cell Lymphoma

American Journal of Hematology, Volume 101, Issue 4, Page 832-863, April 2026.
ABSTRACT Diffuse large B‐cell lymphoma (DLBCL) is the most common type of NHL in the Western Hemisphere. It comprises a heterogenous group of lymphomas, with different biology and clinical prognoses. R‐CHP remains the backbone of therapy, and frontline therapeutic options in fit patients are pola‐R‐CHP and R‐CHOP, whereas elderly or frail/unfit ...
Elise A. Chong, Emily B. Tomasulo, Stefan K. Barta   +2 more
wiley   +1 more source

Comparative Outcomes of Consolidation Strategies After R‐MVP Induction in Primary Diffuse Large B‐Cell Lymphoma of the Central Nervous System

Cancer Medicine, Volume 15, Issue 4, April 2026.
ABSTRACT Background The optimal consolidation strategy following high‐dose methotrexate (MTX)–based induction in primary central nervous system lymphoma (PCNSL) remains controversial. This study compared real‐world outcomes of different consolidation modalities in patients responsive to rituximab, MTX, vincristine, and procarbazine (R‐MVP) induction ...
Sang‐A Kim, Jung Sun Kim, Ji Yun Lee, Joo Ho Lee, Keun‐Yong Eom, Chul‐Kee Park, Chae‐Yong Kim, Dae Seog Heo, Jeong‐Ok Lee, Tae Min Kim   +9 more
wiley   +1 more source

DNA methylation in follicular lymphoma [PDF]

, 2010
PhDFollicular Lymphoma (FL) is a common B cell Non-Hodgkin Lymphoma with a median survival of 8-10 years. Patients frequently undergo transformation to a more aggressive lymphoma and this is associated with drastically reduced survival.
Ó Riain, Ciarán Liam
core   +4 more sources

Molecular Pathogenesis of MALT lymphoma [PDF]

, 2011
Mucosa associated lymphoid tissue (MALT) lymphoma is characterized by t(11;18)(q21;q21)/API2-MALT1, t(1;14)(p22;q32)/BCL10-IGH and t(14;18)(q32;q21)/IGH-MALT1, which commonly activate the NF-κB pathway.

core   +2 more sources